Brittany Trang

Brittany Trang, a health tech reporter at Stat News, dives into the transformative role of AI in healthcare. She discusses how AI scribes are alleviating burdens during clinical visits and explores the rise of patient-facing chatbots like ChatGPT Health. Brittany highlights the risks of AI giving misleading clinical advice, emphasizing the importance of nuance in medical judgments. The conversation also touches on the benefits of AI in predictive modeling and reducing administrative tasks, while critiquing tech companies that oversell AI capabilities in health.

Biotech reporter Jonathan Wosen discusses the NIH's significant funding cuts and the looming brain drain that could push young researchers overseas. Health tech reporter Brittany Trang dives into the skeptical reactions towards AI drug developers like Absci and Generate:Biomedicines, who assert they can create drugs from scratch. The conversation sheds light on the potential impact of reduced NIH support on U.S. biomedical innovation and the challenges of relying on AI in drug discovery.

Brittany Trang, a STAT colleague and AI expert in the healthcare sector, joins to discuss the FDA's new AI tool, ELSA, which struggles with rectifying past mistakes. She sheds light on Sanofi's $9 billion acquisition of Blueprint Medicines and how it's shaking up the biotech landscape. The conversation also delves into Novo Nordisk's challenges in the obesity drug market, focusing on their strategic errors and the implications of leadership changes, while raising ethical questions about aggressive marketing.

Brittany Trang, a health tech reporter for Stat News, dives into the evolving role of AI in healthcare. They explore how AI scribes are alleviating doctors' paperwork burdens and the emergence of health chatbots like ChatGPT Health. Brittany raises concerns about the reliability of these AI models, noting significant risks of misinformation. The discussion highlights the mixed feelings among doctors regarding AI tools, balancing patient access to information with the threat of harmful advice. Ultimately, they examine AI's potential beyond chatbots, emphasizing its practical uses in reducing clinician workloads.

Guests Brittany Trang and Rachel Cohrs Zhang discuss AI in drug development, Medicare coverage for GLP-1 drugs, H5N1 bird flu outbreak, and proposals for obesity drug coverage in Washington, with insights on the first presidential debate's healthcare topics.